17/04/2007 - The European biotech industry has managed to bounce back after a long-lasting period of restructuring that began in 2005 and there is now reason for optimism, according to new research.After years of downturn and painful restructuring, the European biotech industry is firmly back on the right path and is sustaining its newfound progress and momentum, Ernst & Young said in a new report on the biotech industry released this week. >>> Discuss This Story
